https://scholars.lib.ntu.edu.tw/handle/123456789/189578
標題: | The Angio-Seal (Tm) Arterial Closure Device for Early Ambulation after Elective Percutaneous Coronary Intervention in Patients Receiving Low-Dose Enoxaparin | 作者: | LAI, YUNG-CHANG HSIEN-LI KAO YEN-HUNG LIN MAO-SHIN LIN YI-LWUN HO CHIA-LUN CHAO |
關鍵字: | ENOXAPARIN;UNFRACTIONATED HEPARIN;ANGIO-SEAL (TM);VASCULAR CLOSURE DEVICE;PERCUTANEOUS CORONARY INTERVENTION | 公開日期: | 2008 | 卷: | 36 | 期: | 5 | 起(迄)頁: | 1077 | 來源出版物: | JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 摘要: | This study evaluated the efficacy and safety of use of the Angio-Seal vascular closure device deployment for early ambulation (2 h) after elective percutaneous coronary intervention in 143 consecutive patients receiving either intravenous low-dose enoxaparin (0.5 mg/kg) or unfractionated heparin (UFH). The initial success rate of Angio-Seal(trade mark) deployment was 98.6%, with no significant difference between the UFH group (98.9%) and the enoxaparin group (98.0%). In-hospital and clinic outcomes were evaluated in the 141 patients with successful Angio- Seal deployment. During hospitalization, there were no deaths, myocardial infarction, urgent target vessel revascularization or bleeding events in either group; three patients in the UFH group and none in the enoxaparin group had minor vascular complications (differences not significant). In clinic follow-up, two patients in the UFH group and none in the enoxaparin group had major vascular complications (differences not significant). Routine use of the Angio-Seal(trade mark) for early ambulation in patients receiving intravenous low-dose enoxaparin compared with UFH provides promising efficacy and safety for daily practice. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/174564 https://www.scopus.com/record/display.uri?eid=2-s2.0-54449086836&origin=inward&txGid=9e9d5d502f3663dc9cf0edb5337b2d0d |
DOI: | 10.1177/147323000803600527 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。